Finance

Lists
MERK:IDX
Merck Tbk PT
IDR 3,730.00
+1.08%
(+40.00) 1D
Oct 13, 3:43:13 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for MERK...
Open
IDR 3,670
High
IDR 3,740
Low
IDR 3,660
Mkt. cap
1.67T
Avg. vol.
28.93K
Volume
2.50K
Dividend
7.37%
Quarterly dividend
IDR 69
Ex-dividend date
Jun 8, 2026
P/E ratio
5.02
52-wk high
IDR 4,500
52-wk low
IDR 2,760
EPS
IDR 744
Shares outstanding
448.00M
No. of employees
358
Open
IDR 3,670
High
IDR 3,740
Low
IDR 3,660
Mkt. cap
1.67T
Avg. vol.
28.93K
Volume
2.50K
Dividend
7.37%
Quarterly dividend
IDR 69
Ex-dividend date
Jun 8, 2026
P/E ratio
5.02
52-wk high
IDR 4,500
52-wk low
IDR 2,760
EPS
IDR 744
Shares outstanding
448.00M
No. of employees
358
News stories
From web sources and news partners
About Merck Tbk PT
CEO-
Employees358
Founded1970
Headquarters-
SectorPharmaceutical industry
Websitemerckgroup.com
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
333.95B
386.56B
283.11B
347.13B
Cost of goods sold
181.74B
94.13B
169.45B
230.60B
Cost of revenue
181.74B
94.13B
169.45B
230.60B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63.77B
49.96B
45.62B
60.16B
Operating expense
52.93B
101.14B
34.81B
54.81B
Total operating expenses
234.67B
195.26B
204.27B
285.41B
Operating income
99.28B
191.29B
78.84B
61.72B
Other non operating income
-
-
-
-
EBT including unusual items
102.44B
193.74B
84.21B
67.43B
EBT excluding unusual items
102.44B
193.73B
84.21B
67.45B
Income tax expense
22.85B
51.95B
19.03B
20.84B
Effective tax rate
22.31%
26.81%
22.60%
30.90%
Other operating expenses
-10.84B
51.17B
-10.81B
-5.35B
Net income
79.59B
141.80B
65.18B
46.60B
Net profit margin
23.83%
36.68%
23.02%
13.42%
Earnings per share
-
-
-
-
Interest and investment income
3.96B
3.30B
5.32B
6.07B
Interest expense
-489.95M
-623.99M
-112.45M
-1.10B
Net interest expenses
3.47B
2.68B
5.21B
4.97B
Depreciation and amortization charges
-
-
-
-
EBITDA
105.71B
197.84B
85.40B
68.17B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps